Colin G Chinn, M.D. Internal Medicine - Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 3475 N Saratoga St, Oak Harbor, WA 98278 Phone: 360-257-9974 |
News Archive
Patients with postoperative recurrent non-small-cell lung cancer harbouring epidermal growth factor receptor mutations have longer progression-free and overall survival with gefitinib treatment, than those with stage IV disease, Japanese researchers report.
Children diagnosed with sleep-disordered breathing appear to sleep better and have improved behavior following removal of their tonsils and adenoids, according to a report in the October issue of Archives of Otolaryngology-Head & Neck Surgery.
The developing world is expected to account for more than half of all cancer cases in the world by 2020 say medical experts.
Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that preclinical data presented at the AACR-NCI-EORTC Conference on Molecular Targets and Cancer Therapeutics shows that STA-9090, a novel, synthetic inhibitor of heat shock protein 90 (Hsp90), demonstrated strong activity in multiple tumor models.
Ankle sprains may predispose a patient to osteoarthritis according to a study presented at the American Orthopaedic Foot and Ankle Society's Annual Winter Meeting in Washington, DC.
› Verified 3 days ago